Results 51 to 60 of about 5,044 (233)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension

Annals of Clinical and Translational Neurology, 2020
Objective The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.
Jung‐Ick Byun, Do‐Yong Kim, Jangsup Moon, Hye-Rim Shin, Jun‐Sang Sunwoo, Woo‐Jin Lee, Han‐Sang Lee, Kyung‐Il Park, Soon‐Tae Lee, Keun‐Hwa Jung, Ki‐Young Jung, Manho Kim, Sang Kun Lee, Kon Chu   +13 more
doaj   +1 more source

Oral Midodrine as an Adjunct in Rapid Weaning of Intravenous Vasopressor Support in Spinal Cord Injury

Asian Journal of Neurosurgery, 2023
Background  Majority of acute cervical spinal cord injury end up requiring long-term stay in intensive care unit (ICU). During the initial few days after spinal cord injury, most patients are hemodynamically unstable requiring intravenous vasopressors ...
Arunkumar Sekar, Debajyoti Datta, Avinash Lakha, S. S. Jena, S. Bansal, R. Sahu   +5 more
semanticscholar   +1 more source

Role of Midodrine on Vasopressor Duration in Patients with Sepsis

Journal of Shock and Hemodynamics, 2023
Existing literature evaluating the off-label use of midodrine has focused primarily on postoperative hypotensive patients requiring a single vasopressor.
Kamah Ellena, Jenna Combs, Heather Draper, Julie Belfer   +3 more
semanticscholar   +1 more source

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOrthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 ...
Carlos G. Grijalva, Italo Biaggioni, Marie R. Griffin, Cyndya A. Shibao   +3 more
doaj   +1 more source

Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study

Liver international (Print)
Nonselective beta‐blockers (NSBB) are the mainstay for treatment of portal hypertension (PH), but require caution in decompensated cirrhosis (DC) or acute‐on‐chronic liver failure (ACLF) with hypotension, hyponatremia, acute kidney injury (AKI) or type 2
C. Vashishtha, Ankit Bhardwaj, Ankur Jindal, Manoj Kumar, S. Sarin   +4 more
semanticscholar   +1 more source

Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis

BMJ Open, 2022
Introduction Intensive care unit (ICU) lengths of stay are modified by ongoing need for haemodynamic support in critically ill patients. This is most commonly provided by intravenous vasopressor therapy.
Oleksa G Rewa, Sean M Bagshaw, Bram Rochwerg, Janek Senaratne, Xiaoming Wang, Kirsten Fiest, Jim Kutsogiannis, Wendy Sligl, Dawn Opgenorth, Vincent Lau, Mostafa Kamaleldin, Sebastian Kilcommons, Constantine Jason Karvellas, Erika MacIntyre, Jocelyn Slemko   +14 more
doaj   +1 more source

Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide [PDF]

Frontiers in Medicine, 2017
Hyponatremia in the setting of cirrhosis is a common electrolyte disorder with few therapeutic options. The free water retention is due to non-osmotic vasopressin secretion resulting from the cirrhosis-associated splanchnic vasodilatation. Therefore, vasoconstrictive therapy may correct this electrolyte abnormality.
Minh-Kevin Nguyen, Minhtri K. Nguyen, Sharad Patel, Dai-Scott Nguyen, Anjay Rastogi   +4 more
openaire   +3 more sources

Progress of non‐motor symptoms in early‐onset Parkinson's disease

Ibrain, EarlyView.
This study reviews the research progress related to non‐motor symptoms (NMS) in patients with early onset Parkinson's disease (EOPD), including neuropsychiatric symptoms, autonomic dysfunction, sleep disorders, and sensory disorders and also summarizes the characteristics of NMS in the genetic form of Parkinson's disease (PD).
Fanshi Zhang, Aidi Luo, Shusheng Liao, Mei Liu, Jun Zhang, Zucai Xu   +5 more
wiley   +1 more source

The Impact of Midodrine on Guideline-Directed Medical Therapy in Patients Admitted With Systolic Heart Failure

medRxiv, 2023
: Midodrine is occasionally used off-label to treat hypotension associated with advanced heart failure (HF); however, its association with changes in prescription of guideline-directed medical therapy (GDMT) is unknown.
Christopher Scoma, Dae Hyun Lee, David B Money, G. Eichelberger, A. Usmani, Adam J Cohen, Joel Fernandez   +6 more
semanticscholar   +1 more source

The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Pregnancy after a Parkinson's diagnosis presents complex challenges. Due to the paucity of literature, there is no evidence‐based guidelines and protocols for preconception care, management of pregnancy, childbirth and the postpartum period in women with early‐onset Parkinson's disease (PD).
Alexander C. Lehn, Jee‐Young Lee, Giorgia Sciacca, Stacy Patterson, Adam Morton, Paul Pun, Walaa A. Kamel, Marina Picillo, Bart Post, Eng‐King Tan, Tamine Capato, Bastiaan R. Bloem, Manon Auffret, Annelien M. Oosterbaan, Willanka Kapelle, Michiko K. Bruno, Lorraine V. Kalia, Jeffrey H. Kordower, Daniela Berg   +18 more
wiley   +1 more source